Lea Krutzke

658 total citations
14 papers, 135 citations indexed

About

Lea Krutzke is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Lea Krutzke has authored 14 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Lea Krutzke's work include Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Lea Krutzke is often cited by papers focused on Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Lea Krutzke collaborates with scholars based in Germany, China and United States. Lea Krutzke's co-authors include Stefan Kochanek, R. Rosler, Tatjana Engler, Sebastian Wiese, Thomas A. Engler, Andrew P. Byrnes, Florian Kreppel, Thomas Simmet, Christoph Q. Schmidt and Katharina Landfester and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Lea Krutzke

13 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Krutzke Germany 7 78 66 34 28 15 14 135
Greyson Biegert United States 8 94 1.2× 34 0.5× 54 1.6× 10 0.4× 12 0.8× 15 155
Joost van Haasteren Switzerland 5 233 3.0× 94 1.4× 24 0.7× 17 0.6× 8 0.5× 6 287
Michael T. Lam United States 5 55 0.7× 46 0.7× 31 0.9× 15 0.5× 5 0.3× 9 119
Emad Behboudi Iran 10 42 0.5× 41 0.6× 43 1.3× 72 2.6× 14 0.9× 39 187
Philip L. Felgner United States 3 252 3.2× 123 1.9× 19 0.6× 21 0.8× 11 0.7× 4 323
Sarah Aref United Kingdom 4 63 0.8× 104 1.6× 80 2.4× 27 1.0× 20 1.3× 4 213
Н. А. Орлова Russia 10 135 1.7× 35 0.5× 12 0.4× 37 1.3× 30 2.0× 32 286
Mario Chan United Kingdom 10 139 1.8× 156 2.4× 34 1.0× 65 2.3× 10 0.7× 12 353
Joshua Robinson United States 4 276 3.5× 50 0.8× 38 1.1× 33 1.2× 7 0.5× 6 347
Daphné Laubreton France 10 97 1.2× 33 0.5× 39 1.1× 28 1.0× 11 0.7× 18 267

Countries citing papers authored by Lea Krutzke

Since Specialization
Citations

This map shows the geographic impact of Lea Krutzke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Krutzke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Krutzke more than expected).

Fields of papers citing papers by Lea Krutzke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Krutzke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Krutzke. The network helps show where Lea Krutzke may publish in the future.

Co-authorship network of co-authors of Lea Krutzke

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Krutzke. A scholar is included among the top collaborators of Lea Krutzke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Krutzke. Lea Krutzke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kissmann, Ann‐Kathrin, Xing Hu, Roger Hasler, et al.. (2025). An Aptamer-Based gFET-Sensor for Specific Quantification of Gene Therapeutic Human Adenovirus Type 5. Biosensors. 15(9). 605–605.
2.
Peters, Sarah, et al.. (2024). An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting. PubMed. 32(4). 200909–200909. 2 indexed citations
3.
Krutzke, Lea, Markus Rojewski, Philip H. Zeplin, et al.. (2023). Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas. Viruses. 15(1). 218–218. 3 indexed citations
4.
Krutzke, Lea, Massimiliano Cadamuro, Jens von Einem, et al.. (2023). Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer. International Journal of Molecular Sciences. 24(11). 9255–9255. 9 indexed citations
5.
Seidel, Alina, Fabrice Klein, Rüdiger Groß, et al.. (2023). Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice. Frontiers in Immunology. 14. 1231274–1231274. 1 indexed citations
6.
Schmidt, Christoph Q., Markus Rojewski, Philip H. Zeplin, et al.. (2022). Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells. Molecular Therapy — Methods & Clinical Development. 25. 96–110. 3 indexed citations
7.
Krutzke, Lea, et al.. (2022). Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine. eLife. 11. 31 indexed citations
8.
Fiedler, Erik, et al.. (2022). Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor. Biomaterials Advances. 144. 213208–213208. 6 indexed citations
9.
Singh, Karmveer, Karin Scharffetter‐­Kochanek, Markus Rojewski, et al.. (2021). Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells. Viruses. 13(6). 1136–1136. 4 indexed citations
10.
Krutzke, Lea, et al.. (2020). Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses. Human Gene Therapy. 31(19-20). 1100–1113. 12 indexed citations
11.
Wagner, Jessica, Longjie Li, Johanna Simon, et al.. (2020). Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5. Angewandte Chemie International Edition. 59(14). 5712–5720. 21 indexed citations
12.
Wagner, Jessica, Longjie Li, Johanna Simon, et al.. (2020). Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5. Angewandte Chemie. 132(14). 5761–5769. 2 indexed citations
13.
Krutzke, Lea, et al.. (2020). EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids. International Journal of Molecular Sciences. 21(24). 9535–9535. 10 indexed citations
14.
Krutzke, Lea, Thomas A. Engler, Christoph Q. Schmidt, et al.. (2016). Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity. Journal of Controlled Release. 235. 379–392. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026